Biotechnology
Austria
France
Unitedstates
Vaccines
Development
Commercialization
M&A Advisory
Lazard
Full Credential Description
Valneva. Austria, France, United States. Announced Date 30/04/2020. Closed Date 15/06/2020. Deal value: $308m. Valneva and Pfizer Collaboration in relation to Lyme Disease Vaccine VLA15. Industry: Valneva is a biotechnology company specializing in the development and commercialization of vaccines.